Dados B3 › RPAD3 × ITSA4
RPAD3 × ITSA4
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | RPAD3 | ITSA4 | year |
|---|---|---|---|
| ROE | 8.4%! | 18.4% | 2025 |
| ROIC | 7.7% | 18.4%! | 2025 |
| ROA | 8.2% | 14.7% | 2025 |
| Gross margin | 94.8% | 31.5% | 2020 |
| EBIT margin | 34,974.2%! | 131.4%! | 2020 |
| Net margin | 35,003.1% | 124.9% | 2020 |
| Net debt/EBITDA | -1.87x | 0.25x | 2025 |
| Current ratio | 13.90x | 3.18x | 2025 |
| Revenue growth (1y) | -100.0%! | 38.9% | 2021 |
| Revenue growth (5y CAGR) | -12.5% | 3.8% | 2020 |
| Piotroski F-Score | 5/9! | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | RPAD3 | ITSA4 | year |
|---|---|---|---|
| P/E | 5.46x | 9.10x | 2025 |
| P/B | 0.44x | 1.69x | 2025 |
| EV/EBITDA | 4.51x | 7.99x | 2025 |
| FCF yield | — | -0.5% | 2025 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-09 13:39 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.